LAA CLOSURE II: TECHNICAL CONSIDERATIONS

Saturday, March 8, 2025

3:49 PM - 4:35 PM ET

Moderator(s)

Stefan Bertog, MD

Cardioligist
CardioVascular Center Frankfurt
St Paul, Minnesota, United States

Disclosure information not submitted.
Luis Augusto Palma Dallan, MD, PhD

Physician
University Hospitals Cleveland Medical Center
Ashland, Ohio, United States

No relationships to disclose
Jonathan Schwartz, MD

Enterprise Director of Cardiovascular Innovation, Structural Interventional Cardiologist
Sanger Heart & Vascular Institute, North Carolina, United States

No relationships to disclose

Disclosure(s):

Stefan Bertog, MD: Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)

Luis Augusto Palma Dallan, MD, PhD: No financial relationships to disclose

Jonathan Schwartz, MD: Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Cordis: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); CorFlow Therapeutics: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Lifelens LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); RapidAI: Consultant (Ongoing); Siemens: Consultant (Ongoing); W.L. Gore & Associates: Consultant (Ongoing)